82 results
8-K
RNLX
Renalytix Plc
24 Jun 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:15pm
of the Private Securities Litigation Reform Act of 1995, as amended. This information includes, without limitation, statements concerning the Company's intention
8-K
EX-99.1
RNLX
Renalytix Plc
17 Jun 24
Regulation FD Disclosure
4:30pm
-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Examples of these forward-looking statements
8-K
EX-10.1
RNLX
Renalytix Plc
12 Jun 24
Departure of Directors or Certain Officers
5:00pm
or litigation; (ii) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities
424B5
6i32p6xldx5qkcjno873
15 May 24
Prospectus supplement for primary offering
10:09am
8-K
EX-1.1
m84obs
15 May 24
Entry into a Material Definitive Agreement
9:23am
8-K
EX-99.1
xppj66
15 May 24
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
7:00am
424B3
0762nh8r4me7q3gbx39
7 May 24
Prospectus supplement
6:29pm
8-K
hiiik0mmv 9gfxea7
26 Apr 24
Allotment and issue of the Second Tranche Placing Shares
7:43am
8-K
lugsid
9 Apr 24
Entry into a Material Definitive Agreement
4:51pm
424B5
sicjfhfxv7qgs15ro
9 Apr 24
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
or7tvgng1 mk
8 Apr 24
Regulation FD Disclosure
7:44am
8-K
EX-10.1
zp3xdz6f z8omvkdfpke
29 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-99.1
hllvld 92
14 Mar 24
Guidelines highlight the importance of risk prediction and personalized treatment to reduce risk
7:15am
8-K
EX-99.2
onm2kk4w re5zz3
13 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
1fnsr
13 Mar 24
Entry into a Material Definitive Agreement
7:00am